S&P 500 Industrials Sector SEC Filings — February 09, 2026

10-02-2026

Teradata Corp /DE/ filed an 8-K on February 10, 2026 (AccNo: 0001628280-26-006830), reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. This constitutes a standard voluntary disclosure of financial results typical for earnings announcements. No specific revenue, earnings, guidance, or other quantitative metrics are disclosed in the provided filing details.

10-02-2026

DIODES INC /DEL/ filed a Form 8-K on February 10, 2026 (AccNo: 0001193125-26-044898), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results but specific metrics such as revenue, earnings, guidance, or period-over-period changes are NOT_DISCLOSED. No positive or negative performance indicators, transaction details, or scheduled events are mentioned.

10-02-2026

Forgent Power Solutions, Inc. filed a multi-item Form 8-K on February 10, 2026, reporting entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), and material modifications to rights of security holders (Item 3.03), alongside changes in directors or officers and compensatory arrangements (Item 5.02) and amendments to articles of incorporation or bylaws (Item 5.03). While the material agreement may represent strategic advancement, the equity sales and rights modifications raise concerns over potential dilution and altered shareholder protections. No quantitative transaction values, financial impacts, or performance metrics are disclosed.

10-02-2026

Mattel Inc. /DE/ filed an 8-K on February 10, 2026 (AccNo: 0001628280-26-006840, Size: 813 KB), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing disclosing financial results. No specific revenue, earnings, guidance, or other metrics are mentioned; all quantitative details are NOT_DISCLOSED.

10-02-2026

O-I Glass, Inc. /DE/ filed a Form 8-K on February 10, 2026, under Items 2.02 (Results of Operations and Financial Condition) and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, guidance, balance sheet details, or period-over-period comparisons are disclosed in the provided filing information. This is an informational filing with no quantitative metrics available for analysis.

10-02-2026

Hinge Health, Inc. filed an 8-K on February 10, 2026 (AccNo: 0001628280-26-006826), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, revenue figures, earnings, period-over-period comparisons, guidance, or other quantitative details are disclosed in the provided filing information. This is a multi-item filing likely related to financial results announcement.

10-02-2026

Artificial Intelligence Technology Solutions Inc. filed a Form 8-K on February 10, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the other events, transaction values, financial metrics, or exhibits are disclosed in the provided filing summary.

10-02-2026

DuPont de Nemours, Inc. filed a Form 8-K on February 10, 2026 (AccNo: 0001666700-26-000007), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing disclosing financial results, likely an earnings release. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative metrics are mentioned in the provided filing details.

10-02-2026

Destiny Media Technologies Inc. filed an 8-K on 2026-02-10 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits are included. No specific details on positions affected, individuals involved, reasons for change, or compensation amounts are disclosed.

10-02-2026

REGENXBIO Inc. filed a Form 8-K on February 10, 2026 (AccNo: 0001193125-26-043342), reporting under Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific core events, transactions, financial metrics, or quantitative data are disclosed in the provided filing summary. This is a multi-item filing with no details on timing relative to events or materiality.

10-02-2026

urban-gro, Inc. filed a Form 8-K on February 10, 2026, disclosing under Item 1.01 its entry into a Material Definitive Agreement. Item 9.01 lists Financial Statements and Exhibits. No specific details on the agreement, transaction value, financial impacts, or other metrics are provided in the filing summary.

10-02-2026

Lottery.com Inc. filed an 8-K on February 10, 2026, disclosing under Item 5.07 the submission of matters to a vote of security holders, likely related to a shareholder meeting, and under Item 9.01 financial statements and exhibits. No specific vote outcomes, financial metrics, or other quantitative details are provided in the filing summary.

10-02-2026

Southern Missouri Bancorp, Inc. filed an 8-K on February 10, 2026, reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific financial metrics, transactions, guidance, or operational details are disclosed in the filing summary provided. This appears to be a voluntary informational filing with attached exhibits, but content details are NOT_DISCLOSED.

10-02-2026

M2i Global, Inc. filed a Form 8-K on February 10, 2026, under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing likely providing voluntary disclosure of material information with attached exhibits, such as a press release or presentation. No specific financial metrics, transactions, events, or quantitative data are disclosed in the filing summary.

• ·Accession Number: 0001493152-26-005830
• ·Filing size: 9 MB

10-02-2026

Blackbaud Inc filed a Form 8-K on February 10, 2026, under Item 2.02 disclosing results of operations and financial condition. Item 9.01 includes financial statements and exhibits. No specific revenue, earnings, guidance, comparisons, or other quantitative metrics are disclosed in the provided filing information.

10-02-2026

Target Corp filed an 8-K on February 10, 2026, under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the key position affected, individual names, appointment or resignation status, reasons for the change, or timing are provided in the filing summary. No quantitative metrics, financial impacts, or further governance implications are disclosed.

10-02-2026

Marriott International Inc. filed an 8-K on February 10, 2026, under Items 2.02 (Results of Operations and Financial Condition) and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative metrics are disclosed in the provided filing information. No positive or negative performance indicators, segment details, or outlook revisions are mentioned.

10-02-2026

Masco Corp /DE/ filed an 8-K on February 10, 2026, under Item 2.02 disclosing results of operations and financial condition, and Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, margins, period-over-period changes, guidance, or other quantitative financial metrics are disclosed in the filing description. This is an informational earnings-related disclosure without detailed performance data.

10-02-2026

S&P Global Inc. filed a Form 8-K on 2026-02-10 under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits), indicating a financial results announcement likely related to quarterly or annual earnings. No specific revenue, earnings, guidance, or other financial metrics are disclosed in the provided filing metadata. This is a standard multi-item 8-K for earnings release with attached exhibits.

10-02-2026

Phio Pharmaceuticals Corp. filed an 8-K on February 10, 2026, under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the other events, financial statements, or exhibits are disclosed. No quantitative metrics, positive or negative changes, or period-over-period comparisons are mentioned.

10-02-2026

Fifth Third Bancorp filed an 8-K on February 10, 2026, reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing providing voluntary disclosure of material non-public information with attached exhibits. No quantitative financial metrics, transaction details, or performance comparisons are disclosed in the filing summary.

10-02-2026

Genprex, Inc. filed a Form 8-K on February 10, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events or the content of the financial statements and exhibits are disclosed in the provided filing summary. No quantitative metrics, positive or negative changes, or material transactions are mentioned.

10-02-2026

Oxbridge Re Holdings Ltd filed a Form 8-K on February 10, 2026, under Item 7.01 Regulation FD Disclosure, indicating a voluntary release of material non-public information, and Item 9.01 Financial Statements and Exhibits, which attaches supporting documents. No specific details, financial metrics, transactions, or quantitative data are disclosed in the provided filing summary. This appears to be an informational filing without directional financial impact.

10-02-2026

Middlefield Banc Corp filed a Form 8-K on February 10, 2026 (AccNo: 0001437749-26-003578), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific quantitative financial metrics, period-over-period comparisons, revenue, earnings, balance sheet changes, guidance, or other numerical data are disclosed in the provided filing information. This is an informational earnings-related disclosure with no directional performance indicators available.

10-02-2026

Prudential Financial Inc filed an 8-K on February 10, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers), Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. Specific details including the key position affected, names, reasons for change, appointment or resignation status, and timing are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.

10-02-2026

NextTrip, Inc. filed an 8-K on February 10, 2026, under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details on the content of the Regulation FD disclosure, financial statements, exhibits, transactions, metrics, or events are provided. This is a multi-item voluntary filing with no disclosed quantitative impacts.

10-02-2026

Reliance Global Group, Inc. filed a Form 8-K on 2026-02-10 reporting entry into a material definitive agreement under Item 1.01 and unregistered sales of equity securities under Item 3.02, accompanied by Regulation FD disclosure (Item 7.01) and financial statements/exhibits (Item 9.01). This is a multi-item mandatory filing with no specific transaction details, dollar values, share counts, or financial impacts disclosed. No positive or negative metrics provided, resulting in purely informational disclosure.

10-02-2026

ADDENTAX GROUP CORP. filed an 8-K on February 10, 2026, under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the reported events, transactions, financial metrics, or exhibits are disclosed in the provided filing information. No quantitative data, positive or negative metrics, or performance comparisons are mentioned.

10-02-2026

Farmers National Banc Corp /OH/ filed a Form 8-K on February 10, 2026, disclosing under Item 5.03 amendments to Articles of Incorporation or Bylaws or a change in Fiscal Year, under Item 5.07 submission of matters to a vote of security holders, under Item 7.01 Regulation FD Disclosure, and under Item 9.01 Financial Statements and Exhibits. No specific details, financial metrics, transaction values, vote outcomes, amendment descriptions, or quantitative impacts are disclosed in the provided filing summary. This is a multi-item informational filing with no directional financial implications evident.

10-02-2026

StoneBridge Acquisition II Corp filed an 8-K on February 10, 2026 (AccNo: 0001829126-26-001192) under Item 8.01 Other Events announcing a Merger/Acquisition event. No specific details on deal structure, parties involved, valuation, financial terms, or impacts are disclosed in the provided filing summary. Sector is not specified, and no quantitative metrics, positive or negative changes, or scheduled events are mentioned.

10-02-2026

Lattice Semiconductor Corp filed a Form 8-K on 2026-02-10 under Item 2.02 disclosing results of operations and financial condition, and Item 9.01 for financial statements and exhibits. No specific revenue, earnings, guidance, or period-over-period comparisons are disclosed in the provided filing information. Sector is not specified.

10-02-2026

Genasys Inc. filed an 8-K on February 10, 2026 (AccNo: 0001193125-26-044673, Size: 419 KB), disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. This is a multi-item filing reporting financial results, but specific revenue, earnings, balance sheet details, guidance, or period-over-period comparisons are NOT_DISCLOSED in the provided filing information. No positive, negative, or flat performance metrics are available for analysis.

10-02-2026

Permian Basin Royalty Trust filed a Form 8-K on February 10, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the other events, financial statements, exhibits, transactions, metrics, or impacts are disclosed in the provided filing summary. This is a multi-item informational filing with no directional financial data available.

10-02-2026

Upstart Holdings, Inc. filed a Form 8-K on February 10, 2026, reporting Results of Operations and Financial Condition under Item 2.02 and including Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, balance sheet effects, guidance, or period-over-period comparisons were disclosed in the provided filing information. This is a standard earnings-related disclosure without quantitative details available for analysis.

10-02-2026

Claros Mortgage Trust, Inc. filed an 8-K on February 10, 2026 (AccNo: 0001193125-26-044627), disclosing an event under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for change, timing, or any financial impacts are disclosed. This appears to be a routine governance disclosure without quantified metrics or directional implications.

10-02-2026

INTERNATIONAL BATTERY METALS LTD. filed a Form 8-K on February 10, 2026, under Items 2.02 (Results of Operations and Financial Condition), 3.02 (Unregistered Sales of Equity Securities), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results alongside unregistered equity securities sales, but no specific revenue, earnings, transaction values, or quantitative metrics are provided in the filing description. No positive or negative performance indicators, period-over-period comparisons, or guidance changes are mentioned.

10-02-2026

National Bank Holdings Corp filed a Form 8-K on February 10, 2026 (AccNo: 0001475841-26-000006, Size: 9 MB), reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing likely involving voluntary disclosure of material information and attached exhibits, but specific details of the disclosure, financial metrics, transactions, or events are NOT_DISCLOSED.

10-02-2026

Capital Bancorp Inc filed an 8-K on February 10, 2026 (AccNo: 0001419536-26-000012), disclosing an officer change under Item 5.02 covering departures of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements. Item 9.01 notes financial statements and exhibits. No specific details on positions affected, individuals, reasons, timing, or quantitative impacts are disclosed.

• ·Event Type: Officer Change
• ·Source: us_sec
• ·File Size: 4 MB

10-02-2026

Douglas Emmett Inc filed an 8-K on February 10, 2026, disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the provided information. This is a standard earnings-related voluntary disclosure with a filing size of 12 MB.

10-02-2026

Danaher Corp /DE/ filed an 8-K on February 10, 2026, under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on affected positions, individuals involved, reasons for the change, timing, or any quantitative terms such as compensation amounts are disclosed.

10-02-2026

Artisan Partners Asset Management Inc. filed a Form 8-K on February 10, 2026, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the other events or exhibits disclosed in the provided information. No financial metrics, positive or negative changes, or impacts are mentioned.

10-02-2026

German American Bancorp, Inc. filed an 8-K on February 10, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific details on the core event, financial metrics, transactions, or other quantitative data are disclosed in the provided filing summary. The filing has AccNo: 0000714395-26-000007 and size of 3 MB.

10-02-2026

Cambridge Acquisition Corp. filed an 8-K on 2026-02-10 disclosing entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), amendments to articles of incorporation or bylaws and/or change in fiscal year (Item 5.03), other events (Item 8.01), and financial statements and exhibits (Item 9.01). No quantitative metrics, financial terms, parties involved, deal structure, or performance comparisons are explicitly stated. This filing indicates a merger/acquisition event but lacks details for comprehensive assessment.

10-02-2026

Rhinebeck Bancorp, Inc. filed a Form 8-K on February 10, 2026 (AccNo: 0001104659-26-012668), reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the nature of the other events, transaction values, financial metrics, or exhibits are disclosed in the provided filing summary. No quantitative data, period-over-period comparisons, positive or negative metrics, or strategic implications are mentioned.

10-02-2026

NBT Bancorp Inc filed an 8-K on February 10, 2026 (AccNo: 0001140361-26-004620, Size: 148 KB) reporting Item 7.01 Regulation FD Disclosure. No specific details, financial metrics, transactions, or events are disclosed in the provided filing information.

10-02-2026

CHINA PHARMA HOLDINGS, INC. filed a Form 8-K on February 10, 2026, reporting entry into a material definitive agreement under Item 1.01 and unregistered sales of equity securities under Item 3.02, with exhibits under Item 9.01. This is a multi-item mandatory disclosure with no specific transaction details, dollar values, share counts, or financial impacts provided. No positive or negative metrics are disclosed.

10-02-2026

VAALCO Energy Inc. filed a Form 8-K on February 10, 2026 (event date same as filing date), reporting under Item 1.01 entry into a material definitive agreement, Item 2.02 results of operations and financial condition, Item 7.01 Regulation FD disclosure, and Item 9.01 financial statements and exhibits. This is a multi-item filing combining a significant transaction announcement with financial updates. No specific transaction details, financial metrics, period-over-period comparisons, dollar values, or performance directions (positive, negative, or flat) are disclosed in the provided information.

• ·AccNo: 0000894627-26-000005; Filing size: 21 MB (suggests detailed exhibits)
• ·Critical missing information: Filing content, agreement terms, financial metrics/revenue/earnings, balance sheet effects, guidance, dollar values, YoY/QoQ changes, scheduled events (e.g., earnings calls), named counterparties/executives, sector context - limits analysis quality to low confidence

10-02-2026

Udemy, Inc. filed a Form 8-K on February 10, 2026, reporting under Item 8.01 Other Events. No details on the specific nature of the event, financial impacts, quantitative metrics, or comparisons are disclosed. No positive or negative metrics are mentioned.

10-02-2026

FARADAY FUTURE INTELLIGENT ELECTRIC INC. filed an 8-K on February 10, 2026 (AccNo: 0001213900-26-014347), reporting under Item 1.01 entry into a material definitive agreement, Item 8.01 other events, and Item 9.01 financial statements and exhibits. No specific details, dollar values, financial metrics, positive or negative changes, or period-over-period comparisons are disclosed in the provided filing summary. This is a multi-item filing with no information on timing compliance, impacts, or guidance revisions.

10-02-2026

reAlpha Tech Corp. filed an 8-K on 2026-02-10 reporting under Item 3.01 a notice of delisting or failure to satisfy a continued listing rule or standard; transfer of listing, which is a highly material negative event. Item 5.02 discloses departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officers, potentially indicating management instability. No quantitative financial metrics, specific names, dollar values, or further details provided.

10-02-2026

Sutro Biopharma, Inc. filed a Form 8-K on 2026-02-10 reporting Item 1.01 Entry into a Material Definitive Agreement, Item 7.01 Regulation FD Disclosure, and Item 9.01 Financial Statements and Exhibits. No specific details regarding the agreement, transaction terms, financial impacts, or other metrics are disclosed in the provided filing summary. This is a multi-item mandatory filing under SEC rules, but timing compliance and core event details are NOT_DISCLOSED.

10-02-2026

Deluxe Corp filed an 8-K on February 10, 2026, reporting under Item 1.01 entry into a material definitive agreement. No specific details regarding the nature of the agreement, transaction value, parties involved, financial terms, or impacts are disclosed in the provided filing summary. This is a single-item mandatory disclosure with no quantitative metrics or comparisons provided.